Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse.

Substance abuse·2007
Same author

Medicare's Compare databases with a long-term care mission.

Healthcare financial management : journal of the Healthcare Financial Management Association·2004
Same author

The drug discount card: will it cut drug prices for seniors?

Healthcare financial management : journal of the Healthcare Financial Management Association·2004
Same author

Medicare's ambulance fee schedule dispatched.

Healthcare financial management : journal of the Healthcare Financial Management Association·2002
Same author

Medicare's risk-adjusted capitation method.

Journal of health care finance·2002
Same author

Medicare's fee schedule for hospital outpatient care.

Journal of health care finance·2002
Same journal

Highlights from the HFM blog.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Hospitals face challenges from Medicare cost and payment trends.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

The fate of value-based care with an ACA repeal.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Beyond the Medicare annual well visit: maximizing revenue for hospital-owned practices.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Incorporating social determinants into population health management.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Health Care 2020 Part 3: Consolidation.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode
03:49

Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode

Published on: October 11, 2024

Recent developments in Medicare Part D: 7 things providers should know.

Paul L Grimaldi1

  • 1plganalytics@yahoo.com

Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|December 23, 2008
PubMed
Summary
This summary is machine-generated.

Medicare Part D updates for 2007 include higher standard plan costs and persistent coverage gaps. New tools and scrutiny of drug pricing and rebates are also highlighted for providers.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode
03:49

Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode

Published on: October 11, 2024

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

  • Health Policy
  • Pharmaceutical Economics
  • Healthcare Administration

Background:

  • The Medicare Part D program provides prescription drug benefits to eligible beneficiaries.
  • Continuous updates and program adjustments are necessary to address evolving healthcare needs and economic factors.
  • Understanding recent changes is crucial for healthcare providers to effectively guide patients and manage costs.

Purpose of the Study:

  • To inform healthcare providers about significant recent developments in the Medicare Part D program.
  • To highlight key changes affecting beneficiaries and providers, including cost, coverage, and administrative aspects.
  • To provide an overview of new resources and policy shifts impacting prescription drug benefits.

Main Methods:

  • Review of recent policy announcements and program updates from Medicare.
  • Analysis of changes in standard plan costs and coverage gap provisions.
  • Examination of modifications to the national average bid calculation and audit guidelines.
  • Assessment of evolving scrutiny on drug rebates and price concessions.
  • Monitoring of ongoing policy debates regarding negotiated drug prices.

Main Results:

  • The standard Medicare Part D plan cost is increasing for 2007.
  • The coverage gap continues to be a point of dissatisfaction for beneficiaries.
  • The Drug Plan Finder tool has been improved to simplify plan selection.
  • Methodology for calculating the national average bid has been revised.
  • The final Part D audit guide is now available.
  • Increased scrutiny is being applied to rebates and price concessions.
  • Debate surrounding negotiated drug prices has resurfaced.

Conclusions:

  • Healthcare providers must stay informed about Medicare Part D changes to ensure optimal patient care and navigate program complexities.
  • The evolving landscape of Medicare Part D necessitates proactive adaptation by providers regarding plan costs, coverage, and drug pricing.
  • Enhanced tools and increased transparency in pricing mechanisms aim to improve the program's efficiency and beneficiary satisfaction, though challenges remain.